Table 3.
Multivariate analysis of graft survival in the high‐MELD score patients depending on each subgroup
| Variable | p‐value | Hazard ratio | 95% CI |
|---|---|---|---|
| Low MELD group (30–34 points) | |||
| Age, (≥60 years) | 0.76 | 0.83 | 0.25–2.80 |
| Sex (female) | 0.20 | 1.34 | 0.86–2.07 |
| HCC (present) | 0.74 | 0.89 | 0.45–1.78 |
| ACLF (present) | 0.01 | 2.46 | 1.28–4.72 |
| GRWR (0.8–0.99%) | 0.70 | 1.15 | 0.56–2.38 |
| GRWR (≥1%) | 0.70 | 1.15 | 0.56–2.36 |
| HRS (yes) | 0.89 | 1.05 | 0.54–2.02 |
| ICU‐bound (yes) | 0.36 | 0.76 | 0.42–1.36 |
| Vasopressor (yes) | 0.17 | 0.54 | 0.22–1.31 |
| High MELD group (≥35 points) | |||
| Age (≥60 years) | 0.22 | 2.03 | 0.66–6.23 |
| Sex (female) | 0.97 | 1.01 | 0.61–1.66 |
| HCC (present) | 0.31 | 0.65 | 0.29–1.48 |
| ACLF (present) | 0.93 | 0.97 | 0.48–1.95 |
| GRWR (0.8–0.99%) | 0.69 | 0.86 | 0.40–1.83 |
| GRWR (≥1%) | 0.87 | 1.06 | 0.51–2.21 |
| HRS (yes) | 0.56 | 1.19 | 0.66–2.13 |
| ICU‐bound (yes) | 0.98 | 0.99 | 0.59–1.66 |
| Vasopressor (yes) | 0.42 | 1.31 | 0.68–2.52 |
MELD, Model for End‐Stage Liver Disease; CI, confidence interval; HCC, hepatocellular carcinoma; ACLF, acute‐on‐chronic liver failure; GRWR, graft‐to‐recipient weight ratio; HRS, hepatorenal syndrome; ICU, intensive care unit.